|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Result for the year | |||||
| Adjustments for: | |||||
| Other income | |||||
| Depreciation | |||||
| Results on derecognition of subsidiary | |||||
| Share-based compensation | |||||
| Financial income and expenses | |||||
| Results related to derecognition of financial liabilities | |||||
| Results related to financial liabilities measured at FVTPL | |||||
| Income tax expenses / (gains) | |||||
| Changes in deferred income | |||||
| Other changes in working capital | |||||
| Changes in working capital | |||||
| Cash (used in) / generated by operations | |||||
| Corporate income tax (paid) / received | |||||
| Interest received | |||||
| Interest paid | |||||
| Net cash (used in) / generated by operating activities | |||||
| Cash flow from investing activities | |||||
| Purchases of property, plant and equipment | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Proceeds from sale of intellectual property | |||||
| Transaction costs on sale of intellectual property | |||||
| Increase in short-term deposits | |||||
| Decrease in short-term deposits | |||||
| Net cash (used in) / generated by investing activities | |||||
| Cash flow from financing activities | |||||
| Proceeds from issuance of shares, net of transaction costs | |||||
| Proceeds from exercise of share options | |||||
| Repayment of convertible loans | |||||
| Repayment of lease liability | |||||
| Net cash (used in) / generated by financing activities | |||||
| Net (decrease) / increase in cash and cash equivalents | |||||
| Currency effect cash and cash equivalents | |||||
| Cash and cash equivalents, at beginning of the period | |||||
| Cash and cash equivalents at the end of the period | |||||
Loading...
